Joseph M. Beechem
Net Worth

Last updated:

What is Joseph M. Beechem net worth?

The estimated net worth of Dr. Joseph M. Beechem is at least $15,098,458 as of 6 May 2024. He has earned $10,171,098 from insider trading and has received compensation worth at least $4,927,360 in NanoString Technologies, Inc..

What is the salary of Joseph M. Beechem?

Dr. Joseph M. Beechem salary is $615,920 per year as Chief Scientific Officer and Senior Vice President of R&D in NanoString Technologies, Inc..

How old is Joseph M. Beechem?

Dr. Joseph M. Beechem is 67 years old, born in 1958.

What stocks does Joseph M. Beechem currently own?

As insider, Dr. Joseph M. Beechem owns shares in one company:

Company Title Shares Price per share Total value
NanoString Technologies, Inc. (NSTG) Chief Scientific Officer and Senior Vice President of R&D 85,372 $0 $0

What does NanoString Technologies, Inc. do?

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

NSTG logo
NSTG
NanoString Technologies, Inc.

Joseph M. Beechem insider trading

NanoString Technologies, Inc.

Dr. Joseph M. Beechem has made 7 insider trades between 2017-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 142,967 units of NSTG stock on 11 Jun 2021. As of 6 May 2024 he still owns at least 85,372 units of NSTG stock.

Transaction Date Security Shares Price per share Total value Source
Option
Performance Restricted Stock Units 104,545 N/A N/A
Option
Restricted Stock Units 69,697 N/A N/A
Option
Common Stock 34,848 N/A N/A
Option
Common Stock 104,545 N/A N/A
Option
Common Stock 8,460 N/A N/A
Option
Restricted Stock Units 8,460 N/A N/A
Option
Common Stock 34,848 N/A N/A
Option
Restricted Stock Units 2,765 N/A N/A
Option
Common Stock 8,460 N/A N/A
Option
Common Stock 2,765 N/A N/A
Option
Restricted Stock Units 34,848 N/A N/A
Option
Common Stock 8,460 N/A N/A
Option
Restricted Stock Units 8,460 N/A N/A
Option
Common Stock 2,764 N/A N/A
Option
Restricted Stock Units 3,742 N/A N/A
Option
Common Stock 3,742 N/A N/A
Option
Restricted Stock Units 2,764 N/A N/A
Option
Performance Restricted Stock Units 3,038 N/A N/A
Option
Common Stock 3,038 N/A N/A
Sale
Common Stock 2,436 $27.81 $67,740
Option
Restricted Stock Units 5,377 N/A N/A
Option
Common Stock 5,377 N/A N/A
Sale
Common Stock 2,968 $33.06 $98,134
Option
Restricted Stock Units 3,741 N/A N/A
Option
Restricted Stock Units 2,764 N/A N/A
Option
Common Stock 3,741 N/A N/A
Option
Common Stock 2,764 N/A N/A
Option
Common Stock 13,709 N/A N/A
Option
Performance Restricted Stock Units 13,709 N/A N/A
Sale
Common Stock 23,114 $61.19 $1,414,230
Option
Common Stock 142,967 $8.94 $1,278,125
Option
Stock Option (right to buy) 24,999 $6.72 $167,993
Sale
Common Stock 131,827 $59.25 $7,810,750
Sale
Common Stock 8,874 $65.96 $585,329
Sale
Common Stock 2,939 N/A N/A
Sale
Common Stock 2,939 $66.32 $194,914
Option
Restricted Stock Units 5,376 N/A N/A
Option
Common Stock 10,752 N/A N/A
Option
Common Stock 10,752 N/A N/A
Option
Restricted Stock Units 18,432 N/A N/A
Option
Common Stock 18,432 N/A N/A
Option
Restricted Stock Units 3,741 N/A N/A
Option
Common Stock 3,741 N/A N/A
Option
Common Stock 5,376 N/A N/A
Option
Restricted Stock Units 5,376 N/A N/A
Option
Restricted Stock Units 18,431 N/A N/A
Option
Common Stock 18,431 N/A N/A
Option
Common Stock 18,431 N/A N/A
Option
Restricted Stock Units 18,431 N/A N/A
Option
Restricted Stock Units 3,334 N/A N/A
Option
Common Stock 3,334 N/A N/A
Option
Restricted Stock Units 18,431 N/A N/A
Option
Common Stock 18,431 N/A N/A
Option
Restricted Stock Units 18,431 N/A N/A
Option
Common Stock 18,431 N/A N/A
Option
Restricted Stock Units 3,333 N/A N/A
Option
Common Stock 3,333 N/A N/A
Option
Common Stock 4,168 N/A N/A
Option
Restricted Stock Units 4,168 N/A N/A
Option
Restricted Stock Units 3,333 N/A N/A
Option
Common Stock 3,333 N/A N/A
Option
Restricted Stock Units 4,166 N/A N/A
Option
Common Stock 4,166 N/A N/A
Option
Restricted Stock Units 4,166 N/A N/A
Option
Common Stock 4,166 N/A N/A

NanoString Technologies key executives

NanoString Technologies, Inc. executives and other stock owners filed with the SEC: